Susan Hasty, Publisher
Table of Contents . . . September 26th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Retinopathy - Modified receptor could prevent retinal detachment after vitreoretinal surgery
Steroids - Glucocorticoid control of transgene expression may enhance gene therapy
Glioma - Herpes simplex virus persistence in brain cancer cells may pay off in long run
Liver Disease Therapy - Double-conjugated oligonucleotides localize in liver better
Lung Cancer - Gene promoter steers therapy that causes cancer to self-destruct
Urinary Bladder Disease - Hydrochloric acid makes bladder more hospitable to gene therapy
Apoptosis - Preclinical Study: INGN 241 inhibits growth of lung cancer
Chemotherapy - Gene therapy boosts cancer treatment
DNA Sequencing - TIGR, IBEA, and TCAG to create new high-throughput genomic sequencing facility
Finance - Sangamo reports second-quarter financial results
Finance - Second quarter net loss of $0.32 per share reported by gene-based medicine developer
Genomics - SNP Consortium completes genome-based human linkage map
Genomics - Synaptic validates receptor as a promising target for anxiety, depression, obesity
HIV/AIDS Therapy - Sunesis receives NIH grant to develop new HIV therapies
Melanoma - Liposomal trafficking leads antisense molecules directly to destination
Molecular Diagnostics - PerkinElmer exercises option for use of SNP-IT
Restenosis - Synthesized DNA reduces angioplasty failure in treated arteries
Restructuring - Operational changes announced
Sickle Cell Disease - Sangamo gets federal grant to apply ZFP technology
Stem Cell Research - Suicide genes guarantee protection against cellular misbehavior
Thyroid Cancer - Endostatin curbs follicular thyroid carcinoma in animal models
Tumor Immunity - Interleukin-2 gene transfer prevents cancer spread to liver
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.